Active Pharmaceutical Ingredients (APIs)

Product

Last mentioned: Mar 19, 2026

Stories mentioning Active Pharmaceutical Ingredients (APIs) 2

regulation Bearish

US Lawmakers Sound Alarm Over China’s Growing Dominance in Pharma Supply Chain

A high-profile House Select Committee hearing has highlighted the United States' critical dependence on Chinese active pharmaceutical ingredients (APIs). Lawmakers warn that Beijing is applying its successful industrial playbook from rare earths and EVs to corner the global medicine market, with Chinese pharma revenue projected to hit $2.1 trillion by 2030.

3 sources
regulation Bearish

US Lawmakers Warn of Growing Dependence on Chinese Pharmaceutical Supply Chains

US lawmakers are raising alarms over the pharmaceutical industry's reliance on Chinese ingredients, warning that Beijing is applying its 'rare earths playbook' to dominate global medicine. A House Select Committee hearing highlighted concerns that China's control over active pharmaceutical ingredients and the biotech pipeline poses a strategic threat to American healthcare security.

3 sources